ENTITY
SMARTSCORE: 3.2/5
BioNTech

BioNTech (BNTX US)

43
Analysis
Health CareGermany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
21 Dec 2022 02:21Syndicated

CX Daily: What’s in Store for China GDP, Fiscal Policy in 2023

What’s in store for China GDP, fiscal policy in 2023. Hong Kong approval expands mainlanders’ access to mRNA Covid shots. Chinese exporters lose...

Logo
546 Views
Share
15 Dec 2022 06:11Syndicated

CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations

Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...

Logo
547 Views
Share
04 Dec 2022 02:26Syndicated

Weekly Stock Bullfinder - Week of 12/5

As investors we are faced with a deluge of noisy breaking news, business media talking heads, and what has felt like non-stop Fed speakers offering...

Share
bearishPfizer Inc
09 Nov 2022 01:02

Pfizer Inc (PFE.US) - What if Pfizer Loses the China Market in the Future?

Pfizer’s China business faces challenges due to VBP/NRDL negotiation and potential further deterioration of Sino-US relations. Together with...

Logo
239 Views
Share
bearishSK Bioscience
06 Sep 2022 15:15

SK Bioscience (302440 KS): Murky Outlook On Weak Vaccine Demand And Flooding Supply

SK bioscience is a late entrant in the overcrowded COVID-19 vaccine market. Demand for the vaccine is waning globally and is uncertain beyond 2022....

Logo
342 Views
Share
x